These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 1364216

  • 1. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM, Lu C, Su RJ, Wu HP, Tai TY, Lin BJ.
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [Abstract] [Full Text] [Related]

  • 2. Effects of insulin-oral hypoglycemic agents combined therapy in outpatients with type 2 diabetes.
    Sinagra D, Scarpitta AM, Amato M.
    Eur Rev Med Pharmacol Sci; 1998 Feb; 2(5-6):175-9. PubMed ID: 10710815
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP, Patel H, Bahl VK, Bahl S, Mook W.
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [Abstract] [Full Text] [Related]

  • 4. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
    Aguilar CA, Wong B, Gómez-Pérez FJ, Rull JA.
    Rev Invest Clin; 1992 Jun; 44(1):71-6. PubMed ID: 1523352
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of type 2 diabetes. Early detection of secondary oral treatment failure is important].
    Clauson P, Efendic S.
    Lakartidningen; 1999 Jan 20; 96(3):176-81. PubMed ID: 9951232
    [Abstract] [Full Text] [Related]

  • 6. Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.
    Kim G, Lee YH, Kang ES, Cha BS, Lee HC, Lee BW.
    Yonsei Med J; 2016 Nov 20; 57(6):1395-403. PubMed ID: 27593867
    [Abstract] [Full Text] [Related]

  • 7. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S, Estacio RO, Jeffers B, Schrier RW.
    Proc Assoc Am Physicians; 1997 Mar 20; 109(2):181-9. PubMed ID: 9069587
    [Abstract] [Full Text] [Related]

  • 8. Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.
    Trischitta V, Italia S, Borzi V, Tribulato A, Mazzarino S, Squatrito S, Vigneri R.
    Diabetes Care; 1989 Sep 20; 12(8):582-5. PubMed ID: 2505990
    [Abstract] [Full Text] [Related]

  • 9. Before oral agents fail: the case for starting insulin early.
    Marre M.
    Int J Obes Relat Metab Disord; 2002 Sep 20; 26 Suppl 3():S25-30. PubMed ID: 12174320
    [Abstract] [Full Text] [Related]

  • 10. [General insulin therapy practice in type 2 diabetes mellitus].
    Wiesli P, Spinas GA.
    Ther Umsch; 2002 Aug 20; 59(8):402-9. PubMed ID: 12235732
    [Abstract] [Full Text] [Related]

  • 11. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
    Olsson PO, Lindström T.
    Diabetes Metab; 2002 Sep 20; 28(4 Pt 1):272-7. PubMed ID: 12442064
    [Abstract] [Full Text] [Related]

  • 12. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M.
    Ann Acad Med Stetin; 2004 Sep 20; 50(2):29-39. PubMed ID: 16529163
    [Abstract] [Full Text] [Related]

  • 13. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M, Hashizume K.
    Nihon Rinsho; 2006 Jan 20; 64(1):93-8. PubMed ID: 16408454
    [Abstract] [Full Text] [Related]

  • 14. The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy.
    Greco AV, Caputo S, Bertoli A, Ghirlanda G.
    Horm Metab Res; 1992 Jun 20; 24(6):280-3. PubMed ID: 1634193
    [Abstract] [Full Text] [Related]

  • 15. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
    Pontiroli AE, Calderara A, Maffi P, Bonisolli L, Carenini A, Piatti PM, Monti LD, Gallus G, Pozza G, Illeni MT.
    Diabete Metab; 1989 Jun 20; 15(2):79-84. PubMed ID: 2661281
    [Abstract] [Full Text] [Related]

  • 16. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar 20; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 17. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI.
    J Assoc Physicians India; 2002 May 20; 50(5):641-6. PubMed ID: 12186116
    [Abstract] [Full Text] [Related]

  • 18. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis.
    Kalsekar ID, Madhavan SS, Amonkar MM, Douglas SM, Makela E, Elswick BL, Scott V.
    Clin Ther; 2006 Feb 20; 28(2):306-18. PubMed ID: 16678652
    [Abstract] [Full Text] [Related]

  • 19. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
    Ross S, Dzida G, Ji Q, Kaiser M, Ligthelm R, Meneghini L, Nazeri A, Orozco-Beltran D, Pan C, Svendsen AL, SOLVE Study Group.
    J Diabetes; 2014 May 20; 6(3):243-50. PubMed ID: 24103141
    [Abstract] [Full Text] [Related]

  • 20. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM, Kabadi MU.
    J Fam Pract; 1991 Oct 20; 33(4):349-53. PubMed ID: 1919450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.